A peroxynitrite decomposition catalyst prevents 60% O2-mediated rat chronic neonatal lung injury

Free Radical Biology and Medicine

Volumn 49, Issue 7, 2010, Pages 1182-1191

  Masood, Azhar ^a,b   Belcastro, Rosetta ^a   Li, Jun ^a   Kantores, Crystal ^c   Jankov, Robert P ^b,c,d   Tanswell, A Keith ^a,b,d  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c Institute of Clinical Evaluative Sciences   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Alveolar formation; Bronchopulmonary dysplasia; Chronic neonatal lung injury; Free radicals; Oxygen toxicity; Pulmonary hypertension

Indexed keywords

5,10,15,20 TETRAKIS(4 SULFONATOPHENYL)PORPHYRINATOIRON CHLORIDE; 8 ISOPROSTANE; ALPHA SMOOTH MUSCLE ACTIN; ANGIOPOIETIN; FREE RADICAL; HYDROXYL RADICAL; OXYGEN; PEROXYNITRITE; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PORPHYRIN DERIVATIVE; PREPROENDOTHELIN 1; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHRONIC DISEASE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS; LUNG BLOOD VESSEL; LUNG DYSPLASIA; LUNG INJURY; LUNG VOLUME; LUNG WEIGHT; MACROPHAGE; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEUTROPHIL; NEWBORN; NITRATION; NONHUMAN; OXYGEN TOXICITY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAT; TREATMENT OUTCOME; WESTERN BLOTTING;

ANGIOPOIETIN-1; ANIMALS; ANIMALS, NEWBORN; CATALYSIS; HYPERTENSION, PULMONARY; IMMUNOHISTOCHEMISTRY; LUNG; LUNG INJURY; MACROPHAGES; METALLOPORPHYRINS; NEOVASCULARIZATION, PHYSIOLOGIC; NEUTROPHILS; OXYGEN; PEROXYNITROUS ACID; RATS; RATS, SPRAGUE-DAWLEY; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

RATTUS;

EID: 77956173266     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2010.07.001     Document Type: Article

References (60)

1. Coalson J.J. Pathology of chronic lung disease of early infancy. chronic lung disease of early infancy 2000, 85-124. Dekker, New York. R.D. Bland, J.J. Coalson (Eds.).
2. Thibeault D.W., Truog W.E., Ekekezie I.I. Acinar arterial changes with chronic lung disease of prematurity in the surfactant era. Pediatr. Pulmonol. 2003, 36:482-489.
3. Ireys H.T., Anderson G.F., Shaffer T.J., Neff J.M. Expenditure for care of children with chronic illnesses enrolled in the Washington State Medicaid Program, fiscal year 1993. Pediatrics 1997, 100:197-204.
4. Abman S.H. Pulmonary hypertension in chronic lung disease of infancy: pathogenesis, pathophysiology, and treatment. Chronic lung disease of early infancy 2000, 619-668. Dekker, New York. R.D. Bland, J.J. Coalson (Eds.).
5. Rabinovitch M., Gamble W.J., Miettinen O.S., Reid L. Age and sex influence on pulmonary hypertension of chronic hypoxia and on recovery. Am. J. Physiol. Heart Circ. Physiol. 1981, 240:H62-H72.
6. Keith I.M., Tjen A.L.S., Kraiczi H., Ekman R. Three-week neonatal hypoxia reduces blood CGRP and causes persistent pulmonary hypertension in rats. Am. J. Physiol. Heart Circ. Physiol. 2000, 279:H1571-H1578.
7. King A.P., Smith P., Heath D. Ultrastructure of rat pulmonary arterioles after neonatal exposure to hypoxia and subsequent relief and treatment with monocrotaline. J. Pathol. 1995, 177:71-81.
8. Fabris V.E., Pato M.D., Belik J. Progressive lung and cardiac changes associated with pulmonary hypertension in the fetal rat. Pediatr. Pulmonol. 2001, 31:344-353.
9. Meyrick B., Reid L. The effect of chronic hypoxia on pulmonary arteries in young rats. Exp. Lung Res. 1981, 2:257-271.
10. Meyrick B., Reid L. Normal postnatal development of the media of the rat hilar pulmonary artery and its remodelling by chronic hypoxia. Lab. Invest. 1982, 46:505-514.
11. Caslin A., Heath D., Smith P. Influence of hypobaric hypoxia in infancy on the subsequent development of vasoconstrictive pulmonary vascular disease in the Wistar albino rat. J. Pathol. 1991, 163:133-141.
12. Hampl V., Herget J. Perinatal hypoxia increases hypoxic pulmonary vasoconstriction in adult rats recovering from chronic exposure to hypoxia. Am. Rev. Respir. Dis. 1990, 142:619-624.
13. Cutz E., Chaisson D. Chronic lung disease after premature birth. N Engl J. Med. 2008, 358:743-746.
14. Wong P.M., Lees A.N., Louw J., Lee F.Y., French N., Gain K., Murray C.P., Wilson A., Chambers D.C. Emphysema in young adult survivors of moderate-to-severe bronchopulmonary dysplasia. Eur. Respir. J. 2008, 32:321-328.
15. 2. Pediatr. Res. 1996, 39:921-929.
16. 2-mediated pulmonary hypertension in neonatal rats: a role for products of lipid peroxidation. Pediatr. Res. 2000, 48:289-298.
17. 2-induced pulmonary hypertension in the neonatal rat. Pediatr. Res. 2001, 50:172-183.
18. Masood A., Yi M., Lau M., Belcastro R., Shek S., Pan J., Kantores C., McNamara P.J., Kavanagh B.P., Belik J., Jankov R.P., Tanswell A.K. Therapeutic effects of hypercapnia on chronic lung injury and vascular remodeling in neonatal rats. Am. J. Physiol. Lung Cell. Mol. Physiol. 2009, 297:L920-L930.
19. Johnson B.-H., Yi M., Masood A., Belcastro R., Shek S., Kantores C., Jankov R.P., Tanswell A.K. A critical role for interleukin-1 receptor in the lung injury induced in neonatal rats by 60% oxygen. Pediatr. Res. 2009, 66:260-265.
20. Yi M., Jankov R.P., Belcastro R., Humes D., Copland I., Shek S., Sweezey N.B., Post M., Albertine K.H., Auten R.L., Tanswell A.K. Opposing effects of 60% oxygen and neutrophil influx on alveologenesis in the neonatal rat. Am. J. Respir. Crit. Care Med. 2004, 170:1188-1196.
21. Liao L., Ning Q., Li Y., Wang W., Wang A., Wei W., Liu X., Auten R.L., Tanswell A.K., Luo X. CXCR2 blockade reduces radical formation in hyperoxia-exposed newborn rat lung. Pediatr. Res. 2006, 60:299-303.
22. Belik J., Jankov R.P., Pan J., Tanswell A.K. Peroxynitrite inhibits relaxation and induces pulmonary artery muscle contraction in the newborn rat. Free Radic. Biol. Med. 2004, 37:1384-1392.
23. Chabot F., Mitchell J.A., Quinlan G.J., Evans T.W. Characterization of the vasodilator properties of peroxynitrite on rat pulmonary artery: role of poly (adenosine-5′-diphosphoribose) synthase. Br. J. Pharmacol. 1997, 121:485-490.
24. Eichert K., Hamacher J., Wunder A., Wendel A. Intravasal peroxynitrite generation causes dysfunction in the isolated perfused rat lung via endothelin. J. Pharmacol. Exp. Ther. 2001, 297:128-132.
25. 2 exposure enhances vascular and airway smooth muscle contraction in the newborn, but not adult rat. J. Appl. Physiol. 2003, 94:2303-2312.
26. 2Ά upon the newborn rat pulmonary arterial muscle and endothelium. J. Appl. Physiol. 2004, 96:1399-1405.
27. Genovese T., Mazzon E., Esposito E., Muia C., Di Paola R., Bramanti P., Cuzzocrea S. Beneficial effects of FeTSPP, a peroxynitrite decomposition catalyst, in a mouse model of spinal cord injury. Free Radic. Biol. Med. 2007, 43:763-780.
28. Hsu S.M., Raine L., Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 1981, 29:577-580.
29. Yi M., Belcastro R., Shek S., Luo D., Post M., Tanswell A.K. Fibroblast growth factor-2 and receptor-1Ά(IIIc) regulate postnatal rat lung cell apoptosis. Am. J. Respir. Crit. Care Med. 2006, 174:581-589.
30. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
31. Dunnill M.S. Quantitative methods in the study of pulmonary pathology. Thorax 1962, 17:320-328.
32. Kawakami M., Paul J.L., Thurlbeck W.M. The effect of age on lung structure in male BALB/cNNia inbred mice. Am. J. Anat. 1984, 170:1-21.
33. Weibel E.R., Gomez D.M. A principle for counting tissue structures on random sections. J. Appl. Physiol. 1962, 17:343-348.
34. Schittny J.C., Mund S.I., Stampanoni M. Evidence and structural mechanism for late lung alveolarization. Am. J. Physiol. Lung Cell. Mol. Physiol. 2008, 294:L246-L254.
35. 2 receptors mediate pulmonary hypertension in 60% oxygen-exposed newborn rats by a cyclooxygenase-independent mechanism. Am. J. Respir. Crit. Care Med. 2002, 166:208-214.
36. Misko T.P., Highkin M.K., Veenhuizen A.W., Manning P.T., Stern M.K., Currie M.G., Salvemini D. Characterization of the cytoprotective action of peroxynitrite decomposition catalysts. J. Biol. Chem. 1998, 273:15646-15653.
37. Moore K.P., Darley-Usmar V., Morrow J., Roberts L.J. Formation of F2-isoprostanes during the oxidation of human low density lipoprotein by peroxynitrite. Adv. Prostaglandin Thromboxane Leukot. Res. 1995, 23:225-227.
38. Ho Y.S., Liou H.B., Lin J.K., Jeng J.H., Pan M.H., Lin Y.P., Guo H.R., Ho S.Y., Lee C.C., Wang Y.J. Lipid peroxidation and cell death mechanisms in pulmonary epithelial cells induced by peroxynitrite and nitric oxide. Arch. Toxicol. 2002, 76:484-493.
39. Balazy M., Poff C.D. Biological nitration of arachidonic acid. Curr. Vasc. Pharmacol. 2004, 2:81-93.
40. Thébaud B., Abman S.H. Bronchopulmonary dysplasia. Where have all the vessels gone? Roles of angiogenic growth factors in chronic lung disease. Am. J. Respir. Crit. Care Med. 2007, 175:978-985.
41. Platt D.H., Bartoli M., El-Remessy A.B., Al-Shabrawey M., Lemtalsi T., Fulton D., Caldwell R.B. Peroxynitrite increases VEGF expression in vascular endothelial cells via STAT3. Free Radic. Biol. Med. 2005, 39:1353-1361.
42. El-Remessy A.B., Al-Shabrawey M., Platt D.H., Bartoli M., Behzadian M.A., Ghaly N., Tsai N., Motamed K., Caldwell R.B. Peroxynitrite mediates VEGF's angiogenic signal and function via a nitration-independent mechanism in endothelial cells. FASEB J. 2007, 21:2528-2539.
43. Gu X., El-Remessy A.B., Brooks S.E., Al-Shabrawey M., Tsai N.T., Caldwell R.B. Hyperoxia induces retinal vascular endothelial cell apoptosis through formation of peroxynitrite. Am. J. Physiol. Cell Physiol. 2003, 285:C546-C554.
44. El-Remessy A.B., Bartoli M., Platt D.H., Fulton D., Caldwell R.B. Oxidative stress inactivates VEGF survival signaling in retinal endothelial cells via PI 3-kinase tyrosine nitration. J. Cell Sci. 2005, 118:243-252.
45. Jakkula M., Le Cras T.D., Gebb S., Hirth K.P., Tuder R.M., Voelkel N.F., Abman S.H. Inhibition of angiogenesis decreases alveolarization in the developing rat lung. Am. J. Physiol. Lung Cell. Mol. Physiol. 2000, 279:L600-L607.
46. Boström H., Willetts K., Pekny M., Levéen P., Lindahl P., Hedstrand H., Pekna M., Hellström M., Gebre-Medhin S., Schalling M., Nilsson M., Kurland S., Tornell J., Heath J.K., Betsholtz C. PDGF-A signaling is a critical event in lung alveolar myofibroblast development and alveogenesis. Cell 1996, 85:863-873.
47. 2. Pediatr. Res. 2000, 48:423-433.
48. Mamo L.B., Suliman H.B., Giles B.-L., Auten R.L., Claude A., Piantadosi C.A., Nozik-Grayck E. Discordant extracellular superoxide dismutase expression and activity in neonatal hyperoxic lung. Am. J. Respir. Crit. Care Med. 2004, 170:313-318.
49. Yamakura F., Kawasaki H. Post-translational modifications of superoxide dismutase. Biochim. Biophys. Acta 2010, 1804:318-325.
50. Jankov R.P., Negus A., Tanswell A.K. Antioxidants as therapy in the newborn: some words of caution. Pediatr. Res. 2001, 50:681-687.
51. 2 release by lung mitochondria and microsomes. Arch. Biochem. Biophys. 1982, 217:411-421.
52. Thébaud B., Ladha F., Michelakis E.D., Sawicka M., Thurston G., Eaton F., Hashimoto K., Harry G., Haromy A., Korbutt G., Archer S.L. Vascular endothelial growth factor gene therapy increases survival, promotes lung angiogenesis, and prevents alveolar damage in hyperoxia-induced lung injury: evidence that angiogenesis participates in alveolarization. Circulation 2005, 112:2477-2486.
53. Ladha F., Bonnet S., Eaton F., Hashimoto K., Korbutt G., Thébaud B. Sildenafil improves alveolar growth and pulmonary hypertension in hyperoxia-induced lung injury. Am. J. Respir. Crit. Care Med. 2005, 172:750-756.
54. de Visser Y.P., Walther F.J., Laghmani E.H., Boersma H., van der Laarse A., Wagenaar G.T. Sildenafil attenuates pulmonary inflammation and fibrin deposition, mortality and right ventricular hypertrophy in neonatal hyperoxic lung injury. Respir. Res. 2009, 10:30.
55. Alphonse, R. S.; Vadivel, A.; Coltan, L.; Eaton, F.; Barr, A. J.; Dyck, J. R. B.; Thébaud, B. Activation of Akt protects alveoli from neonatal oxygen-induced lung injury. Am. J. Respir. Cell Mol. Biol. in press. doi:10.1165/rcmb.2009-0182OC.
56. Lundberg J.O., Gladwin M.T., Ahluwalia A., Benjamin N., Bryan N.S., Butler A., Cabrales P., Fago A., Feelisch M., Ford P.C., Freeman B.A., Frenneaux M., Friedman J., Kelm M., Kevil C.G., Kim-Shapiro D.B., Kozlov A.V., Lancaster J.R., Lefer D.J., McColl K., McCurry K., Patel R.P., Petersson J., Rassaf T., Reutov V.P., Richter-Addo G.B., Schechter A., Shiva S., Tsuchiya K., van Faassen E.E., Webb A.J., Zuckerbraun B.S., Zweier J.L., Weitzberg E. Nitrate and nitrite in biology, nutrition and therapeutics. Nat. Chem. Biol. 2009, 5:865-869.
57. Ahola T., Fellman V., Kjellmer I., Raivio K.O., Lapatto R. Plasma 8-isoprostane is increased in preterm infants who develop bronchopulmonary dysplasia or periventricular leukomalacia. Pediatr. Res. 2004, 56:88-93.
58. Niu J.O., Munshi U.K., Siddiq M.M., Parton L.A. Early increase in endothelin-1 in tracheal aspirates of preterm infants: correlation with bronchopulmonary dysplasia. J. Pediatr. 1998, 132:965-970.
59. Banks B.A., Ischiropoulos H., McClelland M., Ballard P.L., Ballard R.A. Plasma 3-nitrotyrosine is elevated in premature infants who develop bronchopulmonary dysplasia. Pediatrics 1998, 101:870-874.
60. Been J.V., Debeer A., van Iwaarden J.F., Kloosterboer N., Passos V.L., Naulaers G., Zimmermann L.J. Early alterations of growth factor patterns in bronchoalveolar lavage fluid from preterm infants developing bronchopulmonary dysplasia. Pediatr. Res. 2010, 67:83-89.